» Articles » PMID: 1730481

Characterization of a Cellular Protease That Cleaves Pseudomonas Exotoxin

Overview
Journal Infect Immun
Date 1992 Feb 1
PMID 1730481
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Pseudomonas exotoxin (PE) is a 66-kDa bacterial toxin that is proteolytically cleaved by cells to produce an N-terminal fragment of 28 kDa and a C-terminal 37-kDa fragment which translocates to the cytosol and inhibits protein synthesis (M. Ogata, V.K. Chaudhary, I. Pastan, and D.J. FitzGerald, J. Biol. Chem. 265:20678-20685, 1990). When cells were broken by homogenization, the appropriate proteolytic activity was found associated with cellular membranes and not in a soluble fraction. Proteolysis of PE by crude membranes was stimulated by divalent cations, was ATP independent, and had a pH optimum of 5.5. When cells were disrupted by nitrogen cavitation and fractionated on Percoll gradients, proteolytic activity was present in fractions corresponding to the density of plasma membranes or endosomes but not in fractions containing lysosomes. Proteolytic activity was recovered in detergent extracts after crude membranes were treated with Nonidet P-40 or octylglucoside. Proteolysis of PE by either crude membranes or detergent extracts generated fragments of 28 and 37 kDa. The sizes of these fragments resembled those produced by intact cells. However, when the nontoxic mutant, PEgly276, which cannot be cleaved appropriately by intact cells, was incubated with membranes or extracts there was no production of the 28- and 37-kDa fragments.

Citing Articles

Diagnosis and treatment of hairy cell leukemia as the COVID-19 pandemic continues.

Kreitman R, Arons E Blood Rev. 2021; 51:100888.

PMID: 34535326 PMC: 8418384. DOI: 10.1016/j.blre.2021.100888.


Development of Recombinant Immunotoxins for Hairy Cell Leukemia.

Kreitman R, Pastan I Biomolecules. 2020; 10(8).

PMID: 32756468 PMC: 7464581. DOI: 10.3390/biom10081140.


Glypican-3 Targeting Immunotoxins for the Treatment of Liver Cancer.

Fleming B, Ho M Toxins (Basel). 2016; 8(10).

PMID: 27669301 PMC: 5086635. DOI: 10.3390/toxins8100274.


Immunoconjugates in the management of hairy cell leukemia.

Kreitman R, Pastan I Best Pract Res Clin Haematol. 2015; 28(4):236-45.

PMID: 26614902 PMC: 4663015. DOI: 10.1016/j.beha.2015.09.003.


Toxin-based therapeutic approaches.

Shapira A, Benhar I Toxins (Basel). 2011; 2(11):2519-83.

PMID: 22069564 PMC: 3153180. DOI: 10.3390/toxins2112519.


References
1.
Pastan I, Fitzgerald D . Pseudomonas exotoxin: chimeric toxins. J Biol Chem. 1989; 264(26):15157-60. View

2.
Chaudry G, Wilson R, Draper R, CLOWES R . A dipeptide insertion in domain I of exotoxin A that impairs receptor binding. J Biol Chem. 1989; 264(25):15151-6. View

3.
Morris R, Gerstein A, Bonventre P, Saelinger C . Receptor-mediated entry of diphtheria toxin into monkey kidney (Vero) cells: electron microscopic evaluation. Infect Immun. 1985; 50(3):721-7. PMC: 261139. DOI: 10.1128/iai.50.3.721-727.1985. View

4.
Jiang J, London E . Involvement of denaturation-like changes in Pseudomonas exotoxin a hydrophobicity and membrane penetration determined by characterization of pH and thermal transitions. Roles of two distinct conformationally altered states. J Biol Chem. 1990; 265(15):8636-41. View

5.
Chaudhary V, Jinno Y, Fitzgerald D, Pastan I . Pseudomonas exotoxin contains a specific sequence at the carboxyl terminus that is required for cytotoxicity. Proc Natl Acad Sci U S A. 1990; 87(1):308-12. PMC: 53252. DOI: 10.1073/pnas.87.1.308. View